Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.70014 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Eve P Champaloux and 10 co-authors. Institution: Department of Otolaryngology-Head & Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA. Major MEDLINE topics: Propranolol, Hemangioma, Adrenergic beta-Antagonists, Skin Neoplasms. Cited 1 times so far (Crossref); 12 references.
Abstract (original language)
Objective
Determine if all patients with infantile hemangioma (IH) should undergo cardiology evaluation prior to initiating propranolol therapy or if only select patients should undergo cardiology evaluation, as indicated by a Propranolol Screening Checklist (PSC).
Methods
Retrospective review of 806 IH patients treated with propranolol between 2008 and 2018 at a single tertiary center. Statistical process control methods were used to compare the cardiology recommendations between the pre‐PSC and post‐PSC populations and there was special cause variation after implementation of the checklist.
Results
There were 527 (73.1%) patients referred for cardiology evaluation prior to propranolol initiation for IH before implementation of the PSC compared to 10 (11.5%) patients referred after PSC implementation ( P < .001). There was less testing obtained from patients prior to initiating therapy, like echocardiograms and EKGs. No patients were prevented from initiating therapy throughout the time studied.
Discussion
Cardiology referral prior to initiating propranolol therapy for IH is unnecessary in otherwise healthy infants without concerning signs or symptoms.
Implications for Practice
Propranolol therapy can be instituted safely in most IH patients after screening for the need for cardiology referral. This improves efficiency for families and institutions with high complexity patients. This may avoid the long wait times for specialist care which delays this time‐sensitive intervention.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head & Neck Surgery, University of Washington School of Medicine, Seattle, Washington, USA.
- Otolaryngology Division, Alaska Native Tribal Health Consortium, Ancourage, Alaska, USA.
- Division of Pediatric Otolaryngology-Head & Neck Surgery, Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Pediatrics, University School of Medicine, Division of Cardiology, Seattle Children's Hospital, Seattle, Washington, USA.
- Biostatistics Epidemiology and Analytics for Research (BEAR) Core, Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Dermatology, University of Washington Medical School, Seattle, Washington, USA.
ORCID profiles: Eve P Champaloux
Cite
APA
Champaloux, E. P., Epstein, S., Bull, C., Vernon, M. M., Meyer, S., Lutsky, E., Wang, X., Ganti, S., Gupta, D., Perkins, J. A., & Dahl, J. P. (2025). Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70014
Vancouver
Champaloux EP, Epstein S, Bull C, Vernon MM, Meyer S, Lutsky E, et al. Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.70014
BibTeX
@article{Champaloux2025,
author = {Champaloux, Eve P and Epstein, Sherise and Bull, Catherine and Vernon, Margaret M and Meyer, Shannon and Lutsky, Erika and Wang, Xing and Ganti, Sheila and Gupta, Deepti and Perkins, Jonathan A and Dahl, John P},
title = {Reducing Routine Cardiology Evaluation Prior to Initiating Propranolol for Infantile Hemangiomas},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.70014}
}
EUVIMED